您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
Invivo anti-mouse PD-1 Recombinant mAb (D265A)

Invivo anti-mouse PD-1 Recombinant mAb (D265A)

货号: S0B0594
价格: 700
规格: 1mg
介绍: -
其他: -
产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    PD-1
  • 分子别名

    Programmed cell death protein 1, mPD-1, CD279
  • 细胞定位

    Cell membrane
  • Accession

    Q02242
  • 克隆号

    S-5001
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    Mouse IgG1 D265A, κ
  • 同型对照

    Invivo mouse IgG1 isotype control (D265A)
  • 突变

    D265A
  • 应用

    In vivo blocking of PD-1/PD-L signaling
  • 反应种属 ?

    Ms
  • 纯化方式

    Protein G
  • 浓度

    Lot specific* (generally 5 to 20 mg/ml)*
  • 内毒素含量

    <1EU/mg
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4, containing no preservative

  • 储存条件

    2 to 8 °C for 2 weeks under sterile conditions;

    -20 °C for 3 months under sterile conditions; 

    -80 °C for 24 months under sterile conditions.

    Please avoid repeated freeze-thaw cycles.

  • 稀释度

背景介绍
  • This antibody recognizes the same epitope as clone RMP1-14.

    Programmed cell death protein 1, also known as PD-1 and CD279 (cluster of differentiation 279), is a protein on the surface of T and B cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self-tolerance by suppressing T cell inflammatory activity. This prevents autoimmune diseases, but it can also prevent the immune system from killing cancer cells. PD-1 is an immune checkpoint and guards against autoimmunity through two mechanisms. First, it promotes apoptosis (programmed cell death) of antigen-specific T-cells in lymph nodes. Second, it reduces apoptosis in regulatory T cells (anti-inflammatory, suppressive T cells).

  • 验证数据

    • Anti-tumor efficacy of S0B0594 in B16-OVA tumor-bearing mice

    • Anti-tumor efficacy of S0B0594 in MC38 Xenograft Model